A nurse is instructing a client who is newly diagnosed with pulmonary tuberculosis (TB) about the use of antitubercular medications. Which of the following information should the nurse include in the teaching?

A) Medications will need to be taken for the rest of the client's life, even if the client feels better: While it is crucial for patients with pulmonary tuberculosis (TB) to complete their prescribed treatment regimen, the treatment does not usually extend for the rest of their life. Typically, TB treatment lasts for 6 to 12 months, depending on the type of TB and the patient's response to therapy. Stopping medications prematurely, even if the client feels better, can lead to drug resistance and relapse, so adherence to the full course is critical. However, lifelong treatment is not required. B) The client's family will also need to take medications to prevent infection: In most cases, family members of a person diagnosed with TB do not automatically need to begin antitubercular therapy. However, close contacts of individuals with active pulmonary TB, especially those who are at high risk (e.g., immunocompromised individuals, young children), may need to undergo latent TB screening and, in some cases, preventive treatment. The primary focus is on treating the active infection in the client and preventing the spread of the disease, not indiscriminate medication use for family members. C) A typical course of treatment involves 6 to 12 months of consistent medication use: This is the correct and most accurate information. The treatment for active pulmonary TB typically involves a combination of antibiotics (such as isoniazid, rifampin, pyrazinamide, and ethambutol) over a period of 6 to 12 months, depending on the patient's response to therapy and whether the infection is drug-resistant. The full course of treatment is essential to cure the infection and prevent the development of drug-resistant strains of TB. Adherence to the prescribed treatment regimen is critical, even if the client feels better before completing the full course. D) Medications will need to be taken until the Mantoux test is negative: The Mantoux test (or tuberculin skin test) is used to identify exposure to the tuberculosis bacteria, but it is not used to determine when to stop TB medications. The duration of treatment is based on clinical factors such as the type of TB (active or latent), the patient's response to treatment, and culture results (e.g., sputum tests) to confirm bacterial eradication. A negative Mantoux test does not necessarily correlate with the need to stop antitubercular medications. Instead, the decision to discontinue medications is based on clinical response, sputum culture results, and treatment regimen.